DNA Bridges, Inc. Corporate Logo Bridging Science and Products Industry and Client News on Twitter Like Us on Facebook Business Intelligence on LinkedIn

Developed marketing strategy which lead to $12 million USD in private financing

Cammie Edwards, PhD | Corporate Strategy

Cammie Edwards, PhD has over 20 years of experience in the biopharmaceutical industry. Her early career was in pre-clinical drug development, later moving into corporate development. She has been with DNA Bridges since 2004. In her role at DNA Bridges, she has assisted clients in raising funds (> $20 million in both private and federal funding), corporate positioning, business development, and management of large projects and contracts. Dr. Edwards’ areas of expertise are oncology, inflammation, translational science and biologics development; however, she has worked successfully with both U.S. and international clients in a broad range of areas that also include vaccines, biodefense and biomarker technologies. Prior to working with DNA Bridges/DNA Gateway, Dr. Edwards was as a scientist at Roche Biosciences where she led a group developing novel small molecule therapies for the treatment of fibrotic diseases. At Genentech and Bristol-Myers Squibb, she worked in advancing products in anti-inflammatory programs. Dr. Edwards earned her PhD in Physiology (Molecular and Cellular Biology) from the University of California, Berkeley.



"Cori Gorman has an extraordinarily high level of expertise, which was one of the critical factors in choosing her for this. When things come up again, she is the person I will go to."

- Senior scientist at a biotechnology company.

An independent third party conducted a quality survey for DNA Bridges,Inc. The third party, in association with Dunn and Bradstreet, interviewed several clients. All clients stated that the costs met expectations and projects were competed on time.